tirzepatide and sudafed Compounded (GLP-1/GIP) Tirzepatide reduces food intake and

Losing 5% to 10% of body weight through diet and exercise reduces the risk of cardiovascular disease, but diet and exercise alone are not always guaranteed to address the issue

Selecting the most appropriate GLP-1 receptor agonist requires consideration of multiple patient-specific factors, clinical characteristics, and treatment goals

Key Benefits: Accelerates healing of muscles, tendons, ligaments, and joints Enhances blood vessel growth (angiogenesis) in damaged tissues Reduces pain and inflammation without suppressing immune function Promotes gut health, which supports overall recovery and tissue resilience 2

The most common side effects are typically mild and gastrointestinal-related, such as nausea, especially when starting the medication

R., Pinheiro W

Some patients experience a side effect called hyperesthesia, which causes skin sensitivity or tingling without a rash